MAGNEVIST INJ
Manufacturer Details
ZYDUS CADILA GERM REM
Compositions:
469mg of gadopentate acid dimeglumine salt in aqueous sol/ml 10ml injection,
469mg of gadopentate acid dimeglumine salt in aqueous sol/ml 20ml injection,
|
Strength
|
Rate
|
Packing Style
|
|
469mg
|
144445.00
|
10ml injection
|
|
469mg
|
305714.00
|
20ml injection
|
List of Related Indications:
List Of Drugs:
Indication Type Description:
Drug Interaction:
Drug interaction - summary-
Iodinated contrast material
Parentral contrast studies with iodinated materials can lead to
acute renal failure and have been associated with lactic acidosis
in patients receiving metformin.
Therefore withhold metformin for at least 48 hours prior to and 48 hours
subsequent to the procedure and reintstate only after renal function
has been re-evaluated.
Indication:
Approved by (DCI) Drug Controller GENERAL - India For Marketing
(Ref- IDMA Publication)
Name of Drug Indication Date of Approval
Megulamine Gadoteric Constrast Media 16-10-2002
Adverse Reaction:
Rarely convulsions, rigors, ventricular fibrillation, Pulmonary oedema, circulatory failure, cardiac arrest.
Occassionally anaphylactic shock, Hypersensitivity (dyspnoea, bronchospasm oedema of face and glotitis).
Fatalities have occured. Nausea, Metallic taste, vomiting, sensation of heat, Weakness, dizziness, Paraesthesia, headache, Cough, rhinitis, sweating,
Retching, lachrymation, Visual disturbances, pruritus, Salivary gland enlargement,
Pallor, tachycardia, hypotension.
Contra-Indications:
Meglumine should not be used in cerebral arteriography, femoral & other peripheral arteriographies.
Preparations must never be injected into sub-archnoid space & are definitely contraindicated for myleography.
Sensitivity to iodine, severe cardiovascular disease, macroglobulinemias, pregnancy.
Special precautions:
Severe hepatic/renal damage, dehyration, hypertension, sickle cell disease, hyperthyroidism, lactation.
Dosages/ Overdosage Etc:
Constrast Media
Pregnancy and lactation:
Observe caution
